Truist Securities analyst Barry Jonas downgrades Red Rock Resorts (NASDAQ:RRR) from Buy to Hold.
Interim Results From Ongoing Clinical Study Confirm EB613 Optimized Profile For Osteoporosis Treatment And Potential For Entera’s Next Generation Oral Peptide Platform
Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, reported today interim data from an ongoing Phase 1 study designed to assess
